MBio Diagnostics Announces Rebrand to LightDeck Diagnostics to Reflect Commitment to Its Innovative Waveguide Product Platform
By: Colorado BioScience Association Date: 10/21/2020
MBio Diagnostics, the company taking the point-of-care anywhere with on-the-spot, central lab-quality diagnostics, announced today that it is changing its corporate name to LightDeck Diagnostics. The...
Learn MoreDenver-Boulder among top U.S. life science clusters for the first time
By: Colorado BioScience Association Date: 10/21/2020
The Denver metro area has ranked among the largest U.S. life science markets for the first time, in a new report from CBRE. The report on U.S. life sciences ranks the top clusters in the country. On t...
Learn MoreSummit Biolabs Announces Strategic Collaboration to Develop and Commercialize Saliva Liquid-biopsy Tests for COVID-19 and Head & Neck Cancers
By: Colorado BioScience Association Date: 10/16/2020
Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM...
Learn MorePharmaJet’s Needle-free System to be used in Australian Clinical COVID-19 Trial
By: Colorado BioScience Association Date: 10/07/2020
PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Stratis® Needle-free Injection System will be used to deliver a vaccine against SARS-CoV-2 in a clinical...
Learn MoreInvitae completes its $1.4B acquisition of Boulder-based ArcherDX
By: Colorado BioScience Association Date: 10/06/2020
ArcherDX had previously applied for an IPO before the public company its acquisition was announced. Learn more in the Denver Business Journal.
Learn MoreBrickell Biotech Announces Initiation of U.S. Phase 3 Program Evaluating Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis
By: Colorado BioScience Association Date: 10/06/2020
Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitati...
Learn MoreWestminster biotech company shares new strategy for cancer treatments.
By: Colorado BioScience Association Date: 09/29/2020
A Westminster biotech company has a new clinical development strategy following a recent acquisition it made. TriSalus Life Sciences is an emerging immuno-oncology company that has developed technolog...
Learn MoreAspero Medical Receives $310,000 Grant for Development of Pillar™ Micro-Textured Gastrointestinal Endoscopic Balloon Overtube
By: Colorado BioScience Association Date: 09/24/2020
Gastrointestinal endoscopy focused startup company to expand development effort for novel endoscopic single balloon overtube product line. Aspero Medical, a medical device startup focused on developin...
Learn MoreARCA Biopharma files application for Covid-19 drug treatment
By: Colorado BioScience Association Date: 09/22/2020
The company has a drug in its arsenal that it believes could be effective in the treatment of Covid-19 patients. Find out more in the Denver Business Journal.
Learn MoreAmpio Reports Positive Results in Early Trial for IV Ampion treatment in COVID-19 Patients
By: Colorado BioScience Association Date: 09/11/2020
Ampion-treated patients showed improvement from severe disease/hospitalization to uninfected/ambulatory on the ordinal scaleAmpion-treated patients showed greater improvement compared to patients trea...
Learn More